Boehringer Ingelheim has become the latest company to enter the growing market of tumour agnostic medicines with the first KRAS inhibitor. …
Boehringer Ingelheim looking to bring tumour-agnostic trials to Australia
October 31, 2019 Latest News
Latest Video
New Stories
-
Roche welcomes new partnership with government
January 30, 2020 - - Latest News -
MA responds on transparency in the decision-making process
January 30, 2020 - - Latest News -
'Consider the opportunity, not just the cost'
January 30, 2020 - - Latest News -
Didier Dargent: The era of disruption has arrived
January 30, 2020 - - Latest News -
Melissa McGregor leaves a lasting legacy
January 30, 2020 - - Latest News -
Roche teams up with federal government on genome project
January 30, 2020 - - Latest News -
Gilead announces first grants under new HIV program
January 29, 2020 - - Latest News